These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1737361)

  • 1. Control of Ha-ras-mediated mammalian cell transformation by Escherichia coli regulatory elements.
    Liu HS; Scrable H; Villaret DB; Lieberman MA; Stambrook PJ
    Cancer Res; 1992 Feb; 52(4):983-9. PubMed ID: 1737361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parameters affecting the use of the lac repressor system in eukaryotic cells and transgenic animals.
    Wyborski DL; DuCoeur LC; Short JM
    Environ Mol Mutagen; 1996; 28(4):447-58. PubMed ID: 8991077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The function of inducible promoter systems in F9 embryonal carcinoma cells.
    Miller K; Rizzino A
    Exp Cell Res; 1995 May; 218(1):144-50. PubMed ID: 7737354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of smooth muscle alpha-actin promoter in ras-transformed cells: usefulness for setting up reporter gene-based assay system for drug screening.
    Kumar CC; Bushel P; Mohan-Peterson S; Ramirez F
    Cancer Res; 1992 Dec; 52(24):6877-84. PubMed ID: 1458476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SsrA-mediated tagging and proteolysis of LacI and its role in the regulation of lac operon.
    Abo T; Inada T; Ogawa K; Aiba H
    EMBO J; 2000 Jul; 19(14):3762-9. PubMed ID: 10899129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A tightly regulated and reversibly inducible siRNA expression system for conditional RNAi-mediated gene silencing in mammalian cells.
    Wu RH; Cheng TL; Lo SR; Hsu HC; Hung CF; Teng CF; Wu MP; Tsai WH; Chang WT
    J Gene Med; 2007 Jul; 9(7):620-34. PubMed ID: 17486668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of p202, a modulator of apoptosis, during oncogenic transformation of NIH 3T3 cells by activated H-Ras (Q61L) contributes to cell survival.
    Xin H; Geng Y; Pramanik R; Choubey D
    J Cell Biochem; 2003 Jan; 88(1):191-204. PubMed ID: 12461788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IRF-1 reverts the transformed phenotype of oncogenically transformed cells in vitro and in vivo.
    Kröger A; Dallügge A; Kirchhoff S; Hauser H
    Oncogene; 2003 Feb; 22(7):1045-56. PubMed ID: 12592391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SCH 51344 inhibits ras transformation by a novel mechanism.
    Kumar CC; Prorock-Rogers C; Kelly J; Dong Z; Lin JJ; Armstrong L; Kung HF; Weber MJ; Afonso A
    Cancer Res; 1995 Nov; 55(21):5106-17. PubMed ID: 7585559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of oncogene-mediated transformation by ectopic expression of p21Waf1 in NIH3T3 cells.
    Michieli P; Li W; Lorenzi MV; Miki T; Zakut R; Givol D; Pierce JH
    Oncogene; 1996 Feb; 12(4):775-84. PubMed ID: 8632899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased methotrexate resistance and dhfr gene amplification as a consequence of induced Ha-ras expression in NIH 3T3 cells.
    Wani MA; Xu X; Stambrook PJ
    Cancer Res; 1994 May; 54(9):2504-8. PubMed ID: 8162600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Highly controlled heterologous gene expression through combined utilization of the tetracycline-repressible transactivator and the lac repressor.
    Hoshikawa Y; Amimoto K; Mizuguchi R; Hatakeyama M
    Anal Biochem; 1998 Aug; 261(2):211-8. PubMed ID: 9716424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two serum response elements mediate transcriptional repression of human smooth muscle alpha-actin promoter in ras-transformed cells.
    Bushel P; Kim JH; Chang W; Catino JJ; Ruley HE; Kumar CC
    Oncogene; 1995 Apr; 10(7):1361-70. PubMed ID: 7731687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequences 3' of the human c-Ha-ras1 gene positively regulate its expression and transformation potential.
    Colby WW; Cohen JB; Yu D; Levinson AD
    Gene Amplif Anal; 1986; 4():39-52. PubMed ID: 2851530
    [No Abstract]   [Full Text] [Related]  

  • 15. Control of acetate production rate in Escherichia coli by regulating expression of single-copy pta using lacI(Q) in multicopy plasmid.
    Lee SG; Liao JC
    J Microbiol Biotechnol; 2008 Feb; 18(2):334-7. PubMed ID: 18309280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dominant-negative Rac1 suppresses Ras-induced apoptosis possibly through activation of NFkappaB in Ha-ras oncogene-transformed NIH/3T3 cells.
    Chou CK; Liang KH; Tzeng CC; Huang GC; Chuang JI; Chang TY; Liu HS
    Life Sci; 2006 Mar; 78(16):1823-9. PubMed ID: 16274703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolving Lac repressor for enhanced inducibility.
    Satya Lakshmi O; Rao NM
    Protein Eng Des Sel; 2009 Feb; 22(2):53-8. PubMed ID: 19029094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human retinoblastoma gene product prevents c-Ha-ras oncogene mediated cellular transformation of mouse fibroblasts.
    Kivinen L; Pitkänen K; Laiho M
    Oncogene; 1993 Oct; 8(10):2703-11. PubMed ID: 8378082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells.
    Su ZZ; Austin VN; Zimmer SG; Fisher PB
    Oncogene; 1993 May; 8(5):1211-9. PubMed ID: 8479744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ras-interacting domain of Ral GDP dissociation stimulator like (RGL) reverses v-Ras-induced transformation and Raf-1 activation in NIH3T3 cells.
    Okazaki M; Kishida S; Murai H; Hinoi T; Kikuchi A
    Cancer Res; 1996 May; 56(10):2387-92. PubMed ID: 8625316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.